286 related articles for article (PubMed ID: 3088025)
1. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.
Hackeng WH; Lips P; Netelenbos JC; Lips CJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025
[TBL] [Abstract][Full Text] [Related]
2. Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay.
Lindall AW; Elting J; Ells J; Roos BA
J Clin Endocrinol Metab; 1983 Nov; 57(5):1007-14. PubMed ID: 6311857
[TBL] [Abstract][Full Text] [Related]
3. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays.
Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732
[TBL] [Abstract][Full Text] [Related]
4. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay.
Brown RC; Aston JP; Weeks I; Woodhead JS
J Clin Endocrinol Metab; 1987 Sep; 65(3):407-14. PubMed ID: 3624408
[TBL] [Abstract][Full Text] [Related]
5. Immunological evidences for the presence of small late carboxylterminal fragment(s) of human parathyroid hormone (PTH) in circulation in man.
D'Amour P; Labelle F; Wolde-Giorghis R; Hamel L
J Immunoassay; 1989; 10(2-3):191-205. PubMed ID: 2745718
[TBL] [Abstract][Full Text] [Related]
6. Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.
Flueck JA; Di Bella FP; Edis AJ; Kehrwald JM; Arnaud CD
J Clin Invest; 1977 Dec; 60(6):1367-75. PubMed ID: 915003
[TBL] [Abstract][Full Text] [Related]
7. Measurement of parathyroid hormone.
Endres DB; Villanueva R; Sharp CF; Singer FR
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide.
Marx SJ; Sharp ME; Krudy A; Rosenblatt M; Mallette LE
J Clin Endocrinol Metab; 1981 Jul; 53(1):76-84. PubMed ID: 7240381
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism for skeletal resistance in uremia.
Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. Selective determination of C-terminal (70-84) hPTH: elevated concentrations in cholestatic liver disease.
Rittinghaus EF; Jüppner H; Burdelski M; Hesch RD
Acta Endocrinol (Copenh); 1986 Jan; 111(1):62-8. PubMed ID: 3946104
[TBL] [Abstract][Full Text] [Related]
12. The role of circulating N-terminal parathyroid hormone fragments in the early postparathyroid adenomectomy period.
Schachter PP; Christy MD; Shabtay M; Ayalon A; Leight GS
Surgery; 1991 Dec; 110(6):1048-52. PubMed ID: 1745974
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Gao P; D'Amour P
Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
[TBL] [Abstract][Full Text] [Related]
14. Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone.
Gao P; Schmidt-Gayk H; Dittrich K; Nolting B; Maier A; Roth HJ; Seemann O; Reichel H; Ritz E; Schilling T
Clin Chim Acta; 1996 Feb; 245(1):39-59. PubMed ID: 8646814
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19.
D'Amour P; Brossard JH; Räkel A; Rousseau L; Albert C; Cantor T
Clin Chem; 2005 Jan; 51(1):169-76. PubMed ID: 15514090
[TBL] [Abstract][Full Text] [Related]
16. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism.
Goodman WG; Belin T; Gales B; Juppner H; Segre GV; Salusky IB
Kidney Int; 1995 Nov; 48(5):1553-8. PubMed ID: 8544413
[TBL] [Abstract][Full Text] [Related]
17. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
Gautvik KM; Gordeladze JO; Moxheim E; Gautvik VT
Eur Surg Res; 1984; 16 Suppl 2():41-54. PubMed ID: 6723731
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.
Gautvik KM; Gautvik VT; Halvorsen JF
Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic states].
Fukase M; Fujita T; Matsumoto T; Ogata E; Iijima T; Takezawa J; Saito K; Ishige H; Fujimoto M
Nihon Naibunpi Gakkai Zasshi; 1989 Aug; 65(8):807-27. PubMed ID: 2553507
[TBL] [Abstract][Full Text] [Related]
20. Clinical applicability of an amino-terminal radioimmunoassay for determination of parathyroid hormone.
Mollerup CL; Bruun E; Hesselfeldt-Nielsen J; Hummer L
Acta Chir Scand; 1988; 154(7-8):419-23. PubMed ID: 3188789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
